MaxCyte, Inc. - Purchase of Common Stock

RNS Number: 2493 T MaxCyte, Inc. 23 November 2021. Gaithersburg, Maryland, November 23, 2021- M axCyte, Inc.,, a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, announces that...